has been refreshed! Take a tour.
Issue 1121: May 20, 2014

CDC publishes report about two cases of Middle East respiratory syndrome coronavirus infection in the U.S.

On May 14, CDC published an MMWR Early Release titled First Confirmed Cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection in the United States, Updated Information on the Epidemiology of MERS-CoV Infection, and Guidance for the Public, Clinicians, and Public Health Authorities—May 2014. The article was subsequently published in the May 16 issue of MMWR (pages 431–436). The first paragraph is reprinted below.

Since mid-March 2014, the frequency with which cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection have been reported has increased, with the majority of recent cases reported from Saudi Arabia and United Arab Emirates (UAE). In addition, the frequency with which travel-associated MERS cases have been reported and the number of countries that have reported them to the World Health Organization (WHO) have also increased. The first case of MERS in the United States, identified in a traveler recently returned from Saudi Arabia, was reported to CDC by the Indiana State Department of Health on May 1, 2014, and confirmed by CDC on May 2. A second imported case of MERS in the United States, identified in a traveler from Saudi Arabia having no connection with the first case, was reported to CDC by the Florida Department of Health on May 11, 2014. The purpose of this report is to alert clinicians, health officials, and others to increase awareness of the need to consider MERS-CoV infection in persons who have recently traveled from countries in or near the Arabian Peninsula. This report summarizes recent epidemiologic information, provides preliminary descriptions of the cases reported from Indiana and Florida, and updates CDC guidance about patient evaluation, home care and isolation, specimen collection, and travel as of May 13, 2014.

Related Links Back to top

Network for Public Health Law releases report about immunization waivers

On May 9, the Network for Public Health Law released a report titled Issue Brief: Compulsory Immunization Waiver Requirements. This issue brief examines the elements of immunization waivers and provides examples of the various state waiver requirements. It is a clear overview of medical, religious, and philosophical or personal belief exemption laws around the nation with useful information on topics including who can sign a waiver; notarization, witness, and affidavit requirements; required consultation/education laws; renewal requirements, and more.

The Network for Public Health Law provides legal assistance, helpful resources, and opportunities to build connections for local, tribal, state, and federal officials; public health practitioners; attorneys; policy makers; and advocates. Organizations and individuals committed to improving public health can join the Network.

Related Links Back to top

IAC Spotlight! Access up-to-date vaccine package inserts 

Looking for vaccine product information? IAC's Package Inserts web section provides up-to-date product information for all vaccines licensed for use in the United States.

This handy listing is part of IAC’s online Directory of Immunization Resources, which is a compendium of helpful immunization resources—such as apps (applications for mobile devices), blogs, books and periodicals, state and local immunization coalitions, email news services, and more—from a variety of organizations: government, professional associations, nonprofit organizations, private industry, and others.

Related Links Back to top

CDC's May 22 NetConference to focus on measles

CDC will present a Current Issues in Immunization NetConference on Thursday, May 22 from 3:00 to 4:00 p.m. (ET).

Gregory S. Wallace, MD, MS, MPH, will speak on "Why Measles Matters." Andrew Kroger, MD, MPH, will moderate the conference.

This is a limited registration event. Registration (required) will close on May 22 or when the course is full.

Related Links Back to top

"Top Ten Reasons to Protect Your Child by Vaccinating" now available in Spanish

In February, IAC released a new handout for healthcare professionals to share with parents who may be questioning vaccination. Top Ten Reasons to Protect Your Child by Vaccinating is a user-friendly, easy-to-read handout that highlights the seriousness of vaccine-preventable diseases and the importance of vaccination. This handout is now available in Spanish to help reach more parents.

Related Links IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 300 FREE handouts (including translations), which we encourage website users to print out, copy, and distribute widely.

Back to top

IAC updates Spanish translation of "Questions Parents Ask about Vaccinations for Babies"

In February, IAC updated its handout for new parents titled Questions Parents Ask about Vaccinations for Babies. The Spanish translation has now been updated to match the English version.

Related Links Back to top

IAC's sturdy laminated versions of the 2014 U.S. child/teen immunization schedule and the 2014 U.S. adult immunization schedule—order a supply for your healthcare setting today!

IAC's laminated versions of the 2014 U.S. child/teen immunization schedule and the 2014 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given.

The child and adolescent schedule has eight pages (i.e., four double-sided pages) and is folded to measure 8.5" x 11". The adult immunization schedule has six pages (i.e., three double-sided pages) and is folded to measure 8.5" x 11".
IAC's Laminated Child and Teen Immunization SchedulesIAC's Laminated Adult Immunization Schedules
Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Related Link Back to top

CDC study concludes influenza vaccination prevents hospitalization in older people

On May 6, Clinical Infectious Diseases published online an article titled Modeling the effect of different vaccine effectiveness estimates on the number of vaccine prevented influenza associated hospitalizations in older adults. This CDC study used statistical modeling to estimate flu-vaccine-prevented hospitalizations in adults age 65 years and older for estimates of vaccine effectiveness. The first paragraph of a related CDC release is reprinted below.

A new CDC study shows that flu vaccines prevent flu-associated hospitalizations in people 65 years and older, even during seasons when vaccine effectiveness is low. The study reinforces CDC’s existing recommendation for annual vaccination of adults 65 years and older who are at high risk for serious flu-related complications and often most impacted by serious flu disease each year resulting in hospitalization or death.

Related Links Back to top

April issue of CDC's Immunization Works newsletter now available

CDC recently released the April issue of its monthly newsletter Immunization Works and posted it on the website of the National Center for Immunization and Respiratory Diseases (NCIRD). The newsletter offers the immunization community information about current topics. The information is in the public domain and can be reproduced and circulated widely.

Related Link Back to top

Association of Immunization Managers soliciting nominations for the Natalie J. Smith, M.D. Award

The Association of Immunization Managers (AIM) is soliciting nominations for the 2013 Natalie J. Smith, M.D. Award for excellence in program management. The Natalie J. Smith, M.D. Award acknowledges the contributions of an immunization program manager whose leadership has had a significant impact on achieving city, state, territory, and/or national vaccine-preventable disease goals. 

The recipient will be a current or recently retired (within the last two years) immunization program manager who is designated as the person primarily responsible for actively directing one of the 64 city, state, or territorial immunization programs directly funded by the National Center for Immunization and Respiratory Diseases, CDC. This includes the immunization program managers from the 50 states, the District of Columbia, American Samoa, Guam, the Republic of the Marshall Islands, Micronesia, the Northern Mariana Islands, Palau, Puerto Rico, the Virgin Islands, Chicago, New York City, Houston, San Antonio, and Philadelphia.

The award will be presented at the immunization program managers meeting on July 9. 

Nominations must be received by June 13, and should be emailed to Please contact Helen Fox Fields if you have questions.

More background on the award and the nomination form

Back to top

Clinical Vaccinology course to be held in Houston on November 7–9

The National Foundation for Infectious Diseases, the Emory Department of Medicine, Division of Infectious Diseases, and the Emory Vaccine Center are sponsoring a Clinical Vaccinology Course on November 7–9 in Houston, TX. This course focuses on new developments and issues related to the use of vaccines. Expert faculty will provide the latest information on both current and prospective vaccines, updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate vaccination. Continuing education credits are available.

Access more information about the meeting.

Back to top

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .